{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:45:40Z","timestamp":1785782740748,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171277"],"award-info":[{"award-number":["82171277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201432"],"award-info":[{"award-number":["82201432"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301523"],"award-info":[{"award-number":["82301523"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"MOST | National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830038"],"award-info":[{"award-number":["81830038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Intravenous thrombolysis using recombinant tissue plasminogen activator (tPA) remains the primary treatment for patients with acute ischemic stroke (AIS). However, the mechanism of tPA-related hemorrhagic transformation (HT) remains poorly understood. Elevation of histidine-rich glycoprotein (HRG) expression was detected by nano-liquid chromatography tandem mass spectrometry at 1\u2009h following tPA infusion as compared to baseline prior to tPA infusion (discovery cohort,\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200910), which was subsequently confirmed in a validation cohort (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009157) by ELISA. Surprisingly, no elevation of HRG was detected in individuals who subsequently developed HT. During in vitro experiments, HRG reduced neutrophil NETosis, inflammatory cytokine production, and migration across the blood\u2013brain barrier induced by tPA. In a photothrombotic murine AIS model, HRG administration ameliorated HT with delayed thrombolysis, by inhibiting neutrophil immune infiltration and downregulating pro-inflammatory signaling pathways. Neutrophil depletion or NETosis inhibition also alleviated HT, whereas HRG siRNA treatment exacerbated HT. In conclusion, fluctuations in HRG levels may reflect tPA therapy and its associated HT. The inhibitory effect of HRG on neutrophils may counteract tPA-induced immune abnormalities and HT in patients with AIS.\n                  <\/jats:p>","DOI":"10.1038\/s44321-024-00117-y","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T08:02:12Z","timestamp":1723708932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Histidine-rich glycoprotein modulates neutrophils and thrombolysis-associated hemorrhagic transformation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-0648","authenticated-orcid":false,"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8829-8794","authenticated-orcid":false,"given":"Yuexin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2842-3315","authenticated-orcid":false,"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranran","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DeRen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-2309","authenticated-orcid":false,"given":"Luc","family":"Van Kaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-4637","authenticated-orcid":false,"given":"Fu-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"117_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00001721-200412000-00006","volume":"15","author":"DB Borza","year":"2004","unstructured":"Borza DB, Shipulina NV, Morgan WT (2004) Effects of histidine-proline-rich glycoprotein on plasminogen activation in solution and on surfaces. Blood Coagul Fibrinolysis 15:663\u2013672","journal-title":"Blood Coagul Fibrinolysis"},{"key":"117_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.vph.2014.11.007","volume":"64","author":"F Carbone","year":"2015","unstructured":"Carbone F, Vuilleumier N, Bertolotto M, Burger F, Galan K, Roversi G, Tamborino C, Casetta I, Seraceni S, Trentini A et al (2015) Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. Vasc Pharmacol 64:16\u201327","journal-title":"Vasc Pharmacol"},{"key":"117_CR4","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/01.STR.0000131656.47979.39","volume":"35","author":"M Castellanos","year":"2004","unstructured":"Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Davalos A (2004) Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke 35:1671\u20131676","journal-title":"Stroke"},{"key":"117_CR5","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/STROKEAHA.106.481556","volume":"38","author":"M Castellanos","year":"2007","unstructured":"Castellanos M, Sobrino T, Millan M, Garcia M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J et al (2007) Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study. Stroke 38:1855\u20131859","journal-title":"Stroke"},{"key":"117_CR6","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1182\/blood.V78.12.3114.3114","volume":"78","author":"D Collen","year":"1991","unstructured":"Collen D, Lijnen HR (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114\u20133124","journal-title":"Blood"},{"key":"117_CR7","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","volume":"114","author":"M Delvaeye","year":"2009","unstructured":"Delvaeye M, Conway EM (2009) Coagulation and innate immune responses: can we view them separately? Blood 114:2367\u20132374","journal-title":"Blood"},{"key":"117_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/STROKEAHA.106.480111","volume":"38","author":"C Foerch","year":"2007","unstructured":"Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, Alvarez-Sabin J, Wallesch CW, Molina CA, Steinmetz H et al (2007) Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke 38:2491\u20132495","journal-title":"Stroke"},{"key":"117_CR9","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1111\/bph.14711","volume":"176","author":"S Gao","year":"2019","unstructured":"Gao S, Wake H, Gao Y, Wang D, Mori S, Liu K, Teshigawara K, Takahashi H, Nishibori M (2019) Histidine-rich glycoprotein ameliorates endothelial barrier dysfunction through regulation of NF-\u03baB and MAPK signal pathway. Br J Pharmacol 176:2808\u20132824","journal-title":"Br J Pharmacol"},{"key":"117_CR10","doi-asserted-by":"publisher","first-page":"101180","DOI":"10.1016\/j.isci.2020.101180","volume":"23","author":"S Gao","year":"2020","unstructured":"Gao S, Wake H, Sakaguchi M, Wang D, Takahashi Y, Teshigawara K, Zhong H, Mori S, Liu K, Takahashi H et al (2020) Histidine-rich glycoprotein inhibits high-mobility group Box-1-mediated pathways in vascular endothelial cells through CLEC-1A. iScience 23:101180","journal-title":"iScience"},{"key":"117_CR1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Stroke Collaborators (2021) Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20:795\u2013820","DOI":"10.1016\/S1474-4422(21)00252-0"},{"key":"117_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2165\/00003495-199550010-00008","volume":"50","author":"JC Gillis","year":"1995","unstructured":"Gillis JC, Wagstaff AJ, Goa KL (1995) Alteplase. A reappraisal of its pharmacological properties and therapeutic use in acute myocardial infarction. Drugs 50:102\u2013136","journal-title":"Drugs"},{"key":"117_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1177\/0271678X17695572","volume":"37","author":"AM Gori","year":"2017","unstructured":"Gori AM, Giusti B, Piccardi B, Nencini P, Palumbo V, Nesi M, Nucera A, Pracucci G, Tonelli P, Innocenti E et al (2017) Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis. J Cereb Blood Flow Metab 37:3253\u20133261","journal-title":"J Cereb Blood Flow Metab"},{"key":"117_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/lt.25960","volume":"27","author":"J Guo","year":"2021","unstructured":"Guo J, Akahoshi T, Mizuta Y, Murata M, Narahara S, Kawano T, Nagao Y, Zhang S, Tomikawa M, Kawanaka H et al (2021) Histidine-rich glycoprotein alleviates liver ischemia\/reperfusion injury in mice with nonalcoholic steatohepatitis. Liver Transplant 27:840\u2013853","journal-title":"Liver Transplant"},{"key":"117_CR14","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Jama 274:1017\u20131025","journal-title":"Jama"},{"key":"117_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1440-1711.2000.00940.x","volume":"78","author":"MD Hulett","year":"2000","unstructured":"Hulett MD, Parish CR (2000) Murine histidine-rich glycoprotein: cloning, characterization and cellular origin. Immunol Cell Biol 78:280\u2013287","journal-title":"Immunol Cell Biol"},{"key":"117_CR16","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1161\/STROKEAHA.113.002274","volume":"44","author":"D Inzitari","year":"2013","unstructured":"Inzitari D, Giusti B, Nencini P, Gori AM, Nesi M, Palumbo V, Piccardi B, Armillis A, Pracucci G, Bono G et al (2013) MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death. Stroke 44:2901\u20132903","journal-title":"Stroke"},{"key":"117_CR17","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ane.12227","volume":"130","author":"M Karlinski","year":"2014","unstructured":"Karlinski M, Bembenek J, Grabska K, Kobayashi A, Baranowska A, Litwin T, Czlonkowska A (2014) Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis. Acta Neurol Scand 130:305\u2013311","journal-title":"Acta Neurol Scand"},{"key":"117_CR18","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1021\/bi00356a055","volume":"25","author":"T Koide","year":"1986","unstructured":"Koide T, Foster D, Yoshitake S, Davie EW (1986) Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide sequence of its cDNA. Biochemistry 25:2220\u20132225","journal-title":"Biochemistry"},{"key":"117_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89555-z","volume":"11","author":"K Kuroda","year":"2021","unstructured":"Kuroda K, Ishii K, Mihara Y, Kawanoue N, Wake H, Mori S, Yoshida M, Nishibori M, Morimatsu H (2021) Histidine-rich glycoprotein as a prognostic biomarker for sepsis. Sci Rep 11:10223","journal-title":"Sci Rep"},{"key":"117_CR20","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s12031-020-01545-4","volume":"70","author":"J Lee","year":"2020","unstructured":"Lee J, Mun S, Park A, Kim D, Lee YJ, Kim HJ, Choi H, Shin M, Lee SJ, Kim JG et al (2020) Proteomics reveals plasma biomarkers for ischemic stroke related to the coagulation cascade. J Mol Neurosci 70:1321\u20131331","journal-title":"J Mol Neurosci"},{"key":"117_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1172\/JCI112435","volume":"77","author":"LL Leung","year":"1986","unstructured":"Leung LL (1986) Interaction of histidine-rich glycoprotein with fibrinogen and fibrin. J Clin Investig 77:1305\u20131311","journal-title":"J Clin Investig"},{"key":"117_CR22","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1182\/blood.V62.5.1016.1016","volume":"62","author":"LL Leung","year":"1983","unstructured":"Leung LL, Harpel PC, Nachman RL, Rabellino EM (1983) Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 62:1016\u20131021","journal-title":"Blood"},{"key":"117_CR23","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1016\/S0021-9258(19)70451-7","volume":"255","author":"HR Lijnen","year":"1980","unstructured":"Lijnen HR, Hoylaerts M, Collen D (1980) Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 255:10214\u201310222","journal-title":"J Biol Chem"},{"key":"117_CR24","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1161\/STROKEAHA.123.044123","volume":"54","author":"Q Liu","year":"2023","unstructured":"Liu Q, Shi K, Wang Y, Shi FD (2023) Neurovascular inflammation and complications of thrombolysis therapy in stroke. Stroke Stroke 54:2688\u20132697","journal-title":"Stroke Stroke"},{"key":"117_CR25","doi-asserted-by":"publisher","first-page":"107216","DOI":"10.1016\/j.intimp.2020.107216","volume":"90","author":"G Ma","year":"2021","unstructured":"Ma G, Pan Z, Kong L, Du G (2021) Neuroinflammation in hemorrhagic transformation after tissue plasminogen activator thrombolysis: Potential mechanisms, targets, therapeutic drugs and biomarkers. Int Immunopharmacol 90:107216","journal-title":"Int Immunopharmacol"},{"key":"117_CR26","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1182\/blood-2010-07-290551","volume":"117","author":"JL MacQuarrie","year":"2011","unstructured":"MacQuarrie JL, Stafford AR, Yau JW, Leslie BA, Vu TT, Fredenburgh JC, Weitz JI (2011) Histidine-rich glycoprotein binds factor XIIa with high affinity and inhibits contact-initiated coagulation. Blood 117:4134\u20134141","journal-title":"Blood"},{"key":"117_CR27","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1182\/bloodadvances.2022009236","volume":"7","author":"RA Malik","year":"2023","unstructured":"Malik RA, Liao P, Zhou J, Hussain R, Fredenburgh JC, Hettrick L, Revenko AS, Weitz JI (2023) Histidine-rich glycoprotein attenuates catheter thrombosis. Blood Adv 7:5651\u20135660","journal-title":"Blood Adv"},{"key":"117_CR28","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1182\/bloodadvances.2021004567","volume":"5","author":"RA Malik","year":"2021","unstructured":"Malik RA, Zhou J, Fredenburgh JC, Truong TK, Crosby JR, Revenko AS, Weitz JI (2021) Polyphosphate-induced thrombosis in mice is factor XII dependent and is attenuated by histidine-rich glycoprotein. Blood Adv 5:3540\u20133551","journal-title":"Blood Adv"},{"key":"117_CR29","doi-asserted-by":"publisher","first-page":"35046","DOI":"10.1074\/jbc.274.49.35046","volume":"274","author":"SS Mao","year":"1999","unstructured":"Mao SS, Cooper CM, Wood T, Shafer JA, Gardell SJ (1999) Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans. J Biol Chem 274:35046\u201335052","journal-title":"J Biol Chem"},{"key":"117_CR30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1212\/WNL.0b013e3182897015","volume":"80","author":"B Matosevic","year":"2013","unstructured":"Matosevic B, Knoflach M, Werner P, Pechlaner R, Zangerle A, Ruecker M, Kirchmayr M, Willeit J, Kiechl S (2013) Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis. Neurology 80:1216\u20131224","journal-title":"Neurology"},{"key":"117_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.CIR.0000046451.38849.90","volume":"107","author":"J Montaner","year":"2003","unstructured":"Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribo M, Quintana M, Alvarez-Sabin J (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107:598\u2013603","journal-title":"Circulation"},{"key":"117_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12975-010-0047-z","volume":"1","author":"M Ning","year":"2010","unstructured":"Ning M, Sarracino DA, Buonanno FS, Krastins B, Chou S, McMullin D, Wang X, Lopez M, Lo EH (2010) Proteomic protease substrate profiling of tPA treatment in acute ischemic stroke patients: a step toward individualizing thrombolytic therapy at the bedside. Transl Stroke Res 1:268\u2013275","journal-title":"Transl Stroke Res"},{"key":"117_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13054-018-2127-5","volume":"22","author":"M Nishibori","year":"2018","unstructured":"Nishibori M, Wake H, Morimatsu H (2018) Histidine-rich glycoprotein as an excellent biomarker for sepsis and beyond. Crit Care 22:209","journal-title":"Crit Care"},{"key":"117_CR34","doi-asserted-by":"publisher","first-page":"e00481","DOI":"10.1002\/prp2.481","volume":"7","author":"Y Nishimura","year":"2019","unstructured":"Nishimura Y, Wake H, Teshigawara K, Wang D, Sakaguchi M, Otsuka F, Nishibori M (2019) Histidine-rich glycoprotein augments natural killer cell function by modulating PD-1 expression via CLEC-1B. Pharmacol Res Perspect 7:e00481","journal-title":"Pharmacol Res Perspect"},{"key":"117_CR35","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2010-09-303842","volume":"117","author":"IK Poon","year":"2011","unstructured":"Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD (2011) Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood 117:2093\u20132101","journal-title":"Blood"},{"key":"117_CR36","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.biocel.2010.05.008","volume":"42","author":"IK Poon","year":"2010","unstructured":"Poon IK, Yee DY, Jones AL, Wood RJ, Davis DS, Freeman C, Parish CR, Hulett MD (2010) Histidine-rich glycoprotein binds heparanase and regulates its enzymatic activity and cell surface interactions. Int J Biochem cell Biol 42:1507\u20131516","journal-title":"Int J Biochem cell Biol"},{"key":"117_CR37","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50:e344\u2013e418","journal-title":"Stroke"},{"key":"117_CR38","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1182\/bloodadvances.2023011006","volume":"7","author":"AH Schmaier","year":"2023","unstructured":"Schmaier AH (2023) Histidine-rich glycoprotein: antithrombosis without bleeding. Blood Adv 7:5649\u20135650","journal-title":"Blood Adv"},{"key":"117_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCRESAHA.120.317596","volume":"128","author":"K Shi","year":"2021","unstructured":"Shi K, Zou M, Jia DM, Shi S, Yang X, Liu Q, Dong JF, Sheth KN, Wang X, Shi FD (2021) tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke. Circ Res 128:62\u201375","journal-title":"Circ Res"},{"key":"117_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/blood.V91.1.128","volume":"91","author":"T Shigekiyo","year":"1998","unstructured":"Shigekiyo T, Yoshida H, Matsumoto K, Azuma H, Wakabayashi S, Saito S, Fujikawa K, Koide T (1998) HRG Tokushima: molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency. Blood 91:128\u2013133","journal-title":"Blood"},{"key":"117_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4049\/jimmunol.2000817","volume":"206","author":"Y Takahashi","year":"2021","unstructured":"Takahashi Y, Wake H, Sakaguchi M, Yoshii Y, Teshigawara K, Wang D, Nishibori M (2021) Histidine-rich glycoprotein stimulates human neutrophil phagocytosis and prolongs survival through CLEC1A. J Immunol 206:737\u2013750","journal-title":"J Immunol"},{"key":"117_CR42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/MPA.0000000000001153","volume":"47","author":"K Terao","year":"2018","unstructured":"Terao K, Wake H, Adachi N, Liu K, Teshigawara K, Takahashi H, Mori S, Nishibori M (2018) Histidine-rich glycoprotein suppresses hyperinflammatory responses of lung in a severe acute pancreatitis mouse model. Pancreas 47:1156\u20131164","journal-title":"Pancreas"},{"key":"117_CR43","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S1474-4422(18)30323-5","volume":"17","author":"AM Thiebaut","year":"2018","unstructured":"Thiebaut AM, Gauberti M, Ali C, Martinez De Lizarrondo S, Vivien D, Yepes M, Roussel BD (2018) The role of plasminogen activators in stroke treatment: fibrinolysis and beyond. Lancet Neurol 17:1121\u20131132","journal-title":"Lancet Neurol"},{"key":"117_CR44","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.3390\/ijms231810300","volume":"23","author":"N Tomonobu","year":"2022","unstructured":"Tomonobu N, Kinoshita R, Wake H, Inoue Y, Ruma IMW, Suzawa K, Gohara Y, Komalasari N, Jiang F, Murata H et al (2022) Histidine-rich glycoprotein suppresses the S100A8\/A9-mediated organotropic metastasis of melanoma cells. Int J Mol Sci 23:10300","journal-title":"Int J Mol Sci"},{"key":"117_CR45","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.STR.0000126040.99024.cf","volume":"35","author":"P Trouillas","year":"2004","unstructured":"Trouillas P, Derex L, Philippeau F, Nighoghossian N, Honnorat J, Hanss M, Ffrench P, Adeleine P, Dechavanne M (2004) Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases. Stroke 35:1323\u20131328","journal-title":"Stroke"},{"key":"117_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","volume":"22","author":"G Tsivgoulis","year":"2023","unstructured":"Tsivgoulis G, Katsanos AH, Sandset EC, Turc G, Nguyen TN, Bivard A, Fischer U, Khatri P (2023) Thrombolysis for acute ischaemic stroke: current status and future perspectives. Lancet Neurol 22:418\u2013429","journal-title":"Lancet Neurol"},{"key":"117_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1021\/bi001789t","volume":"40","author":"G Tsurupa","year":"2001","unstructured":"Tsurupa G, Medved L (2001) Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains. Biochemistry 40:801\u2013808","journal-title":"Biochemistry"},{"key":"117_CR48","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1182\/blood-2014-11-611319","volume":"125","author":"TT Vu","year":"2015","unstructured":"Vu TT, Zhou J, Leslie BA, Stafford AR, Fredenburgh JC, Ni R, Qiao S, Vaezzadeh N, Jahnen-Dechent W, Monia BP et al (2015) Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood 125:2712\u20132719","journal-title":"Blood"},{"key":"117_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ebiom.2016.06.003","volume":"9","author":"H Wake","year":"2016","unstructured":"Wake H, Mori S, Liu K, Morioka Y, Teshigawara K, Sakaguchi M, Kuroda K, Gao Y, Takahashi H, Ohtsuka A et al (2016) Histidine-rich glycoprotein prevents septic lethality through regulation of immunothrombosis and inflammation. EBioMedicine 9:180\u2013194","journal-title":"EBioMedicine"},{"key":"117_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1182\/blood.2020008913","volume":"138","author":"R Wang","year":"2021","unstructured":"Wang R, Zhu Y, Liu Z, Chang L, Bai X, Kang L, Cao Y, Yang X, Yu H, Shi MJ et al (2021) Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke. Blood 138:91\u2013103","journal-title":"Blood"},{"key":"117_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","volume":"135","author":"W Wang","year":"2017","unstructured":"Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, Wang L, Jiang Y, Li Y, Wang Y et al (2017) Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480\u2009687 adults. Circulation 135:759\u2013771","journal-title":"Circulation"},{"key":"117_CR52","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","volume":"71","author":"S Yaghi","year":"2014","unstructured":"Yaghi S, Eisenberger A, Willey JZ (2014) Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment. JAMA Neurol 71:1181\u20131185","journal-title":"JAMA Neurol"},{"key":"117_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1283","volume":"13","author":"Y Yin","year":"2023","unstructured":"Yin Y, Dai H, Sun X, Xi Z, Zhang J, Pan Y, Huang Y, Ma X, Xia Q, He K (2023) HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation. Clin Transl Med 13:e1283","journal-title":"Clin Transl Med"},{"key":"117_CR54","doi-asserted-by":"publisher","first-page":"e21835","DOI":"10.1096\/fj.202100471RR","volume":"35","author":"S Zhang","year":"2021","unstructured":"Zhang S, Cao Y, Du J, Liu H, Chen X, Li M, Xiang M, Wang C, Wu X, Liu L et al (2021) Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke. FASEB J35:e21835","journal-title":"FASEB J"},{"key":"117_CR55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s13311-023-01377-1","volume":"20","author":"AS Zubair","year":"2023","unstructured":"Zubair AS, Sheth KN (2023) Hemorrhagic conversion of acute ischemic stroke. NeuroTherapeutics 20:705\u2013711","journal-title":"NeuroTherapeutics"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00117-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00117-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:04:06Z","timestamp":1785780246000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00117-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,12]]}},"alternative-id":["117"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00117-y","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LVK is a member of the scientific advisory board of Isu Abxis Co., Ltd. (Republic of Korea). The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"10"}}